Back to 
STATE STREET CORP
STATE STREET CORP
FPRXShowing 0 of 8 quarters
Position history for STATE STREET CORP's holdings in FIVE PRIME THERAPEUTICS INC
As of its Q1 2021 13F, State Street held 1,859,461 shares of FPRX (Five Prime Therapeutics), worth $70M. State Street's 13F filings listed FPRX from Q3 2019 to Q1 2021, 7 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of FPRX: Magnetar Financial LLC, RA CAPITAL MANAGEMENT, L.P., DIMENSIONAL FUND ADVISORS LP, RTW INVESTMENTS, LP, Pentwater Capital Management LP